Research Article

Tomographic Evaluation of Paranasal Sinus findings in COVID-19-Positive Patients

Volume: 5 Number: 2 August 1, 2022

Tomographic Evaluation of Paranasal Sinus findings in COVID-19-Positive Patients

Abstract

Background: Sinonasal symptoms are important in patients with coronavirus disease 2019 during the diagnostic process. This study aimed to evaluate paranasal sinus findings on computed tomography by comparing patients diagnosed with coronavirus disease 2019 and those who were negative for coronavirus disease 2019. Methods: This retrospectively planned study included 163 patients (89 males and 74 females) with positive coronavirus disease 2019 polymerase chain reaction results and 104 patients with negative results for coronavirus disease 2019 (56 males and 48 females) who came to the emergency department for related symptoms. Cranial computed tomography scans routinely performed in symptomatic patients were assessed using the Lund–Mackay scoring system. All sinuses, the ostiomeatal unit, and the right-sided and left-sided sinuses were assessed separately. Mucosal opacities of less than 1 mm were scored as 0, partial opacities that did not completely obliterate the sinus were scored as 1, and opacities that completely obliterated the sinus were scored as 2. Results: In computed tomography scans performed, the mean total Lund–Mackay scores for right-sided sinusitis and left-sided sinusitis in coronavirus disease 2019-positive patients were 1.29 ± 1.9 and 1.26 ± 1.8, respectively. The mean total Lund–Mackay score for right-sided sinusitis in coronavirus disease 2019-negative patients was 1.26 ± 1.7, while it was 1.24 ± 1.7 for left-sided sinusitis. Statistical analysis revealed no significant pathological changes in the paranasal sinuses in the symptomatic coronavirus disease 2019-positive patient group (P > .05) Conclusion: Although coronavirus disease 2019 is a disease with prominent sinonasal symptoms and sampling of the nasal cavity and nasopharynx is essential for diagnosis, no significant difference was determined between the coronavirus disease 2019-positive patient group and the coronavirus disease 2019-negative patient group in terms of paranasal sinus findings.

Keywords

References

  1. Krajewska J, Krajewski W, Zub K, Zatoński T. COVID-19 in otolaryngologist practice: a review of current knowledge. Eur Arch Otorhinolaryngol. 2020;277(7):1885- 1897.
  2. Sumi DV, Loureiro RM, Collin SM, et al. Sinus computed tomography findings in patients with COVID-19. Einstein. 2021;19.
  3. Gengler I, Wang JC, Speth MM, Sedaghat AR. Sinonasal pathophysiology of SARS‐CoV-2 and COVID‐19: a systematic review of the current evidence.
  4. Laryngoscope Investig Otolaryngol. 2020;5(3):354-359.
  5. Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015;152(2):S1-S39.
  6. Blanco CH, Stein JB, Barinsky GL, et al. Management of complicated pediatric rhinosinusitis in the COVID-19 era. Am J Otolaryngol. 2020;41(6):102746.
  7. Naeini AS, Karimi-Galougahi M, Raad N, et al. Paranasal sinuses computed tomography findings in anosmia of COVID-19. Am J Otolaryngol. 2020;41(6):102636.
  8. Li W, Li M, Ou G. COVID‐19, cilia, and smell. FEBS Journal. 2020;287(17): 3672-3676.

Details

Primary Language

English

Subjects

Otorhinolaryngology

Journal Section

Research Article

Publication Date

August 1, 2022

Submission Date

March 26, 2022

Acceptance Date

May 30, 2022

Published in Issue

Year 2022 Volume: 5 Number: 2

APA
Akbal Çufalı, Ş., Yağmur, A. R., Paksoy, Z. B., Çakmak, M. F., Özcan, P. D. K. M., & Aypak, A. (2022). Tomographic Evaluation of Paranasal Sinus findings in COVID-19-Positive Patients. European Journal of Rhinology and Allergy, 5(2), 45-48. https://doi.org/10.5152/ejra.2022.22006
AMA
1.Akbal Çufalı Ş, Yağmur AR, Paksoy ZB, Çakmak MF, Özcan PDKM, Aypak A. Tomographic Evaluation of Paranasal Sinus findings in COVID-19-Positive Patients. Eur J Rhinol Allergy. 2022;5(2):45-48. doi:10.5152/ejra.2022.22006
Chicago
Akbal Çufalı, Şeyda, Ali Rıza Yağmur, Zehra Betül Paksoy, Mehmet Fatih Çakmak, Prof. Dr. Kürşat Murat Özcan, and Adalet Aypak. 2022. “Tomographic Evaluation of Paranasal Sinus Findings in COVID-19-Positive Patients”. European Journal of Rhinology and Allergy 5 (2): 45-48. https://doi.org/10.5152/ejra.2022.22006.
EndNote
Akbal Çufalı Ş, Yağmur AR, Paksoy ZB, Çakmak MF, Özcan PDKM, Aypak A (August 1, 2022) Tomographic Evaluation of Paranasal Sinus findings in COVID-19-Positive Patients. European Journal of Rhinology and Allergy 5 2 45–48.
IEEE
[1]Ş. Akbal Çufalı, A. R. Yağmur, Z. B. Paksoy, M. F. Çakmak, P. D. K. M. Özcan, and A. Aypak, “Tomographic Evaluation of Paranasal Sinus findings in COVID-19-Positive Patients”, Eur J Rhinol Allergy, vol. 5, no. 2, pp. 45–48, Aug. 2022, doi: 10.5152/ejra.2022.22006.
ISNAD
Akbal Çufalı, Şeyda - Yağmur, Ali Rıza - Paksoy, Zehra Betül - Çakmak, Mehmet Fatih - Özcan, Prof. Dr. Kürşat Murat - Aypak, Adalet. “Tomographic Evaluation of Paranasal Sinus Findings in COVID-19-Positive Patients”. European Journal of Rhinology and Allergy 5/2 (August 1, 2022): 45-48. https://doi.org/10.5152/ejra.2022.22006.
JAMA
1.Akbal Çufalı Ş, Yağmur AR, Paksoy ZB, Çakmak MF, Özcan PDKM, Aypak A. Tomographic Evaluation of Paranasal Sinus findings in COVID-19-Positive Patients. Eur J Rhinol Allergy. 2022;5:45–48.
MLA
Akbal Çufalı, Şeyda, et al. “Tomographic Evaluation of Paranasal Sinus Findings in COVID-19-Positive Patients”. European Journal of Rhinology and Allergy, vol. 5, no. 2, Aug. 2022, pp. 45-48, doi:10.5152/ejra.2022.22006.
Vancouver
1.Şeyda Akbal Çufalı, Ali Rıza Yağmur, Zehra Betül Paksoy, Mehmet Fatih Çakmak, Prof. Dr. Kürşat Murat Özcan, Adalet Aypak. Tomographic Evaluation of Paranasal Sinus findings in COVID-19-Positive Patients. Eur J Rhinol Allergy. 2022 Aug. 1;5(2):45-8. doi:10.5152/ejra.2022.22006

You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104

Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.